Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: Implications for impulsivity

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 1, 2008, Pages 27-32

  Congdon, Eliza ^a   Lesch, Klaus Peter ^b   Canli, Turhan ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Dopamine; Endophenotype; Stop signal

Indexed keywords

DNA; DOPAMINE;

ADULT; ALLELE; ARTICLE; BEHAVIOR DISORDER; DAT GENE; DOPAMINE RELEASE; DRD4 GENE; ENDOPHENOTYPE; FEMALE; GENE; GENE CONSTRUCT; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HERITABILITY; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; REACTION TIME; SELF REPORT; STOP SIGNAL TASK PERFORMANCE; TASK PERFORMANCE;

ADOLESCENT; ADULT; ALLELES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; IMPULSIVE BEHAVIOR; INHIBITION (PSYCHOLOGY); MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; VARIATION (GENETICS);

EID: 37849030177     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30557     Document Type: Article

References (45)

1. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
2. Arnsten AFT. 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2(11):436-447.
3. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. 1995. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65(3):1157-1165.
4. Band GP, van der Molen MW, Logan GD. 2003. Horse-race model simulations of the stop-signal procedure. Acta Psychol (Amst) 112(2):105-142.
5. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ. 2001. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292(5526):2499-2501.
6. Carrasco X, Rothhammer P, Moraga M, Henriquez H, Chakraborty R, Aboitiz F, Rothhammer F. 2006. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am J Med Genet Part B 141B(1):51-54.
7. Carver CS, Miller CJ. 2006. Relations of serotonin function to personality: Current views and a key methodological issue. Psychiatry Res 144(1):1-15.
8. Congdon E, Canli T. 2005. The endophenotype of impulsivity: Reaching consilience through behavioral, genetic, and neuroimaging approaches. Behav Cogn Neurosci Rev 4(4):262-281.
9. Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L, Hollis CP. 2005. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 10(7):686-698.
10. Cravchik A, Goldman D. 2000. Neurochemical individuality: Genetic diversity among human dopamine and serotonin receptors and transporters. Arch Gen Psychiatry 57(12):1105-1114.
11. De Geus EJC, Boomsma DI. 2001. A genetic neuroscience approach to human cognition. Eur Psychol 6(4):241-253.
12. de Wit H, Enggasser JL, Richards JB. 2002. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27(5):813-825.
13. Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. 1999. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 19(21):9550-9556.
14. Durston S, Fossella JA, Casey BJ, Hulshoff Pol HE, Galvan A, Schnack HG, Steenhuis MP, Minderaa RB, Buitelaar JK, Kahn RS., et al. 2005. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry 10(7):678-685.
15. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH. 1996. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 12:78-80.
16. Evenden JL. 1999. Varieties of impulsivity. Psychopharmacology (Berl) 146(4):348-361.
17. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1313-1323.
18. Friedel RO. 2004. Dopamine dysfunction in borderline personality disorder: A hypothesis. Neuropsychopharmacology 29(6):1029-1039.
19. Goldberg TE, Weinberger DR. 2004. Genes and the parsing of cognitive processes. Trends Cogn Sci 8(7):325-335.
20. Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160(4):636-645.
21. Hariri AR, Weinberger DR. 2003. Imaging genomics. Br Med Bull 65:259-270.
22. Hunnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP. 2007 Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology [Epub ahead of print].
23. Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, Walters EE, Zaslavsky AM. 2002. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 32(6):959-976.
24. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, et al. 2005. The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol Med 35(2):245-256.
25. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E. 2006. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63(6):669-678.
26. Langbehn DR, Pfohl BM, Reynolds S, Clark LA, Battaglia M, Bellodi L, Cadoret R, Grove W, Pilkonis P, Links P. 1999. The Iowa Personality Disorder Screen: Development and preliminary validation of a brief screening interview. J Pers Disord 13(1):75-89.
27. Langley K, Marshall L, van den Bree M, Thomas H, Owen M, O'Donovan M, Thapar A. 2004. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 161(1):133-138.
28. Li D, Sham PC, Owen MJ, He L. 2006. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15(14):2276-2284.
29. Logan GD. 1994. On the ability to inhibit thought and action: A user's guide to the stop signal paradigm. In: Dagenbach D, Carr TH, editors. Inhibitory processes in attention, memory, and language. San Diego: Academic Press. pp 189-239.
30. Logan GD, Schachar RJ, Tannock R. 1997. Impulsivity and inhibitory control. Psychol Sci 8:60-64.
31. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. 2001. Psychiatric aspects of impulsivity. Am J Psychiatry 158(11):1783-1793.
32. Nigg JT. 2000. On inhibition/disinhibition in developmental psychopathology: Views from cognitive and personality psychology and a working inhibition taxonomy. Psychol Bull 126(2):220-246.
33. Nomura M, Kusumi I, Kaneko M, Masui T, Daiguji M, Ueno T, Koyama T, Nomura Y. 2006. Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior. Psychopharmacology (Berl) 187(1):30-35.
34. Patton JH, Stanford MS, Barratt ES. 1995. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51(6):768-774.
35. Puumala S. 1998. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 83(2):489-499.
36. Robbins TW. 2000. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133(1):130-138.
37. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. 2001. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 105(5):471-478.
38. Rubia K, Smith AB, Brammer MJ, Taylor E. 2003. Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage 20(1):351-358.
39. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA., et al. 1997. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90(6):991-1001.
40. Stoltenberg SF, Glass JM, Chermack ST, Flynn HA, Li S, Weston ME, Burmeister M. 2006. Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene. Psychiatr Genet 16(1):35-38.
41. Szobot C, Roman T, Cunha R, Acton P, Hutz M, Rohde LA. 2005. Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. Am J Med Genet Part B 132B(1):53-58.
42. Tzschentke TM. 2001. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63(3):241-320.
43. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63(6):1767-1776.
44. Winstanley CA, Theobald DE, Cardinal RN, Robbins TW. 2004. Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci 24(20):4718-4722.
45. Winstanley CA, Theobald DE, Dalley JW, Cardinal RN, Robbins TW. 2006. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 16(1):106-114.